Home Halogens 5,7-Dibromoquinolin-8-ol

5,7-Dibromoquinolin-8-ol

CAS No.:
521-74-4
Catalog Number:
AG003MAK
Molecular Formula:
C9H5Br2NO
Molecular Weight:
302.9501
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
95%
In Stock USA
United States
$13
- +
5g
95%
In Stock USA
United States
$25
- +
25g
95%
In Stock USA
United States
$75
- +
100g
95%
In Stock USA
United States
$225
- +
Product Description
Catalog Number:
AG003MAK
Chemical Name:
5,7-Dibromoquinolin-8-ol
CAS Number:
521-74-4
Molecular Formula:
C9H5Br2NO
Molecular Weight:
302.9501
MDL Number:
MFCD00006785
IUPAC Name:
5,7-dibromoquinolin-8-ol
InChI:
InChI=1S/C9H5Br2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H
InChI Key:
ZDASUJMDVPTNTF-UHFFFAOYSA-N
SMILES:
Brc1cc(Br)c2c(c1O)nccc2
EC Number:
208-317-8
UNII:
UK4C618C8T
Properties
Complexity:
191  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
302.872g/mol
Formal Charge:
0
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
302.953g/mol
Monoisotopic Mass:
300.874g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
33.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.2  
Literature
Title Journal
Synthesis and characterization of 8-hydroxyquinoline complexes of tin(IV) and their application in organic light emitting diode. Journal of fluorescence 20120901
New quinoline-5,8-dione and hydroxynaphthoquinone derivatives inhibit a chloroquine resistant Plasmodium falciparum strain. European journal of medicinal chemistry 20120801
High cytotoxicity of dihalo-substituted 8-quinolinolato-lanthanides. Dalton transactions (Cambridge, England : 2003) 20110227
2-[(5,7-Dibromo-quinolin-8-yl)-oxy]-N-(2-meth-oxy-phen-yl)acetamide. Acta crystallographica. Section E, Structure reports online 20101201
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Liquid phase microextraction and ultratrace determination of cadmium by modified graphite furnace atomic absorption spectrometry. Journal of hazardous materials 20090615
In vitro activities of cloxyquin (5-chloroquinolin-8-ol) against Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 20070301
Solid phase extraction vis-à-vis coprecipitation preconcentration of cadmium and lead from soils onto 5,7-dibromoquinoline-8-ol embedded benzophenone and determination by FAAS. Talanta 20060615
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
The evaluation of liposome-water partitioning of 8-hydroxyquinolines and their copper complexes. Environmental science & technology 20060315
A simple spectrophotometric method for the determination of cadmium in industrial, environmental, biological and soil samples using 5,7-dibromo-8-hydroxyquinoline. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20040601
A rapid spectrophotometric method for the determination of molybdenum in industrial, environmental, biological and soil samples using 5,7-dibromo-8-hydroxyquinoline. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20020401
A study on the neurotoxicity of broxyquinoline and brobenzoxaldine combination in therapeutic doses. Human toxicology 19860101
THE IN VITRO EFFECT OF 8-HYDROXYQUINOLINE DERIVATIVES ON STRAINS OF MYCOBACTERIUM TUBERCULOSIS. Biochemical pharmacology 19640201
Properties